시장보고서
상품코드
1935527

두개내 스텐트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Intracranial Stents Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 138 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

두개내 스텐트 시장 규모는 2025년 30억 9,000만 달러에서 2034년에는 51억 2,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 5.78%로 성장할 전망입니다.

두개내 스텐트 시장은 동맥류, 협착증 등 뇌혈관 질환의 유병률 증가를 배경으로 괄목할 만한 성장세를 보이고 있습니다. 전 세계적으로 고령화가 진행되면서 뇌로 가는 혈류에 영향을 미치는 질환의 발생률이 높아짐에 따라 효과적인 치료법에 대한 수요가 급증하고 있습니다. 두개내 스텐트는 혈관을 지지하고 혈류를 개선하는 두개내 스텐트는 이러한 질환 관리에 필수적인 도구입니다. 생체흡수성 스텐트 및 약물 용출형 스텐트 개발 등 스텐트 설계의 혁신으로 스텐트의 효과와 안전성이 향상되어 의료진과 환자 모두에게 더욱 매력적인 선택이 되고 있습니다.

또한 최소침습적 기술의 발전은 두개내 스텐트 시장을 변화시키고 있습니다. 작은 절개를 통해 스텐트를 삽입할 수 있는 혈관내치료의 보급으로 회복기간이 단축되고 환자의 치료성적이 향상되고 있습니다. 의료진이 이러한 기술을 적극적으로 채택함에 따라 해부학적으로 어려운 부위에도 효과적으로 배치할 수 있는 첨단 두개내 스텐트에 대한 수요가 증가할 것으로 예상됩니다. 또한, 수술 중 혈관조영술, 3D 영상 등 영상기술의 통합으로 스텐트 삽입의 정확도가 향상되어 시장 성장을 더욱 촉진하고 있습니다.

또한, 신경학 분야의 연구개발에 대한 관심이 높아지면서 두개내 스텐트 시장의 혁신을 촉진하고 있습니다. 학계, 연구기관, 의료기기 제조업체 간의 협력을 통해 현존하는 문제를 해결하고 환자 치료를 향상시킬 수 있는 차세대 스텐트 개발이 진행되고 있습니다. 뇌혈관 질환에 대한 인식이 높아지고 조기 개입의 중요성에 대한 이해도 시장 확대에 기여하고 있습니다. 요약하면, 두개내 스텐트 시장은 기술 발전, 최소침습 수술에 대한 관심, 뇌혈관 질환 관리에서 환자 예후 개선에 대한 노력으로 인해 견조한 성장이 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 두개내 스텐트 시장 : 제품 유형별

제5장 세계의 두개내 스텐트 시장 : 적응 질환별

제6장 세계의 두개내 스텐트 시장 : 최종사용자별

제7장 세계의 두개내 스텐트 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

KSM 26.03.11

The Intracranial Stents Market size is expected to reach USD 5.12 Billion in 2034 from USD 3.09 Billion (2025) growing at a CAGR of 5.78% during 2026-2034.

The intracranial stents market is experiencing significant growth, driven by the increasing prevalence of cerebrovascular diseases, such as aneurysms and stenosis. As the global population ages and the incidence of conditions that affect blood flow to the brain rises, the demand for effective treatment options is surging. Intracranial stents are essential tools in the management of these conditions, providing support to blood vessels and improving blood flow. Innovations in stent design, including the development of bioresorbable and drug-eluting stents, are enhancing the efficacy and safety of these devices, making them more appealing to healthcare providers and patients alike.

Moreover, advancements in minimally invasive techniques are transforming the intracranial stents market. The rise of endovascular procedures, which allow for the placement of stents through small incisions, is reducing recovery times and improving patient outcomes. As healthcare providers increasingly adopt these techniques, the demand for advanced intracranial stents that can be deployed effectively in challenging anatomical locations is expected to grow. Additionally, the integration of imaging technologies, such as intraoperative angiography and 3D imaging, is enhancing the precision of stent placement, further driving market growth.

Furthermore, the increasing focus on research and development in the field of neurology is fostering innovation in the intracranial stents market. Collaborations between academic institutions, research organizations, and medical device manufacturers are leading to the development of next-generation stents that address current limitations and improve patient care. The growing awareness of cerebrovascular diseases and the importance of early intervention is also contributing to the expansion of the market. In summary, the intracranial stents market is set for robust growth, characterized by technological advancements, a focus on minimally invasive procedures, and a commitment to improving patient outcomes in the management of cerebrovascular conditions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Self-Expanding Stents
  • Balloon Expanding Stents
  • Stent-Assisted Coil Embolization

By Disease Indication

  • Intracranial Stenosis
  • Brain Aneurysm

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • Penumbra Inc, Medtronic, Stryker Corporation, Boston Scientific Corporation, Johnson Johnson Services Inc, Cook Medical, Acandis, Penumbra, Inc, MicroPort Scientific, Phenox, Terumo Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRACRANIAL STENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Self-Expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Balloon Expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Stent-Assisted Coil Embolization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRACRANIAL STENTS MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Disease Indication
  • 5.2. Intracranial Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Brain Aneurysm Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRACRANIAL STENTS MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTRACRANIAL STENTS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product Type
    • 7.2.2 By Disease Indication
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product Type
    • 7.3.2 By Disease Indication
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product Type
    • 7.4.2 By Disease Indication
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product Type
    • 7.5.2 By Disease Indication
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product Type
    • 7.6.2 By Disease Indication
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INTRACRANIAL STENTS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Penumbra Inc
    • 9.2.2 Medtronic
    • 9.2.3 Stryker Corporation
    • 9.2.4 Boston Scientific Corporation
    • 9.2.5 Johnson & Johnson Services Inc
    • 9.2.6 Cook Medical
    • 9.2.7 Acandis
    • 9.2.8 Penumbra, Inc
    • 9.2.9 MicroPort Scientific
    • 9.2.10 Phenox
    • 9.2.11 Terumo Corporation
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제